Clinical trials
Lymphoma, B-Cell, Marginal Zone trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 2 |
| Gilead Sciences | 2 |
| Incyte Corporation | 2 |
| BeOne Medicines | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Hutchmed | 1 |
| Janssen Research & Development, LLC | 1 |
| JaxBio Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 19 |
| Lymphoma, Follicular | 17 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Mantle-Cell | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Non-Hodgkin | 10 |
| Waldenstrom Macroglobulinemia | 9 |
| Lymphoma | 7 |
| Burkitt Lymphoma | 5 |
| Lymphoma, Large-Cell, Immunoblastic | 5 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.